Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v3-EN
Language English English
Date Updated 2024-05-17 2024-04-17
Drug Identification Number 02230848 02230848
Brand name FLOLAN FLOLAN
Common or Proper name Epoprostenol Powder for Injection Epoprostenol Powder for Injection
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients EPOPROSTENOL EPOPROSTENOL
Strength(s) 1.5MG 1.5MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 1s 1s
ATC code B01AC B01AC
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-02-21 2024-02-21
Estimated end date 2024-05-31 2024-05-03
Actual end date 2024-05-16
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments For emergency supply, contact GSK Customer Service at 1-800-387-7374 or cacsu@gsk.com. For emergency supply, contact GSK Customer Service at 1-800-387-7374 or cacsu@gsk.com.
Health Canada comments